Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Peron, V. da Silva, M. de Oliveira, Jr., T. Jazedje, M. Pelatti, C. E. Czeresnia, P. Perin, M. G. Nisenbauum, L. Evangelista, S. Halpern, M. Maluf, M. Zatz, A. P. Ligeiro de Oliveira (Sao Paulo, Brazil). Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice. Eur Respir J 2013; 42: Suppl. 57, 4274

Member's Comments

No comment yet.

Related content which might interest you: Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Exogenous administration of bone marrow-derived stem cells in experimental COPD Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Effect of low level light therapy (LLLT) on an experimental model of LPS-induced lung inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Cell therapy by adipose stromal cells affect tracheal responsiveness and inflammatory responses in guinea pigs model of COPD Source: International Congress 2015 – New models for treating airway diseases Year: 2015 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Therapeutic effects of human perivascular stem cells in an emphysema mouse model Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012